关注
Haritz Moreno Moreno
Haritz Moreno Moreno
Technician at CIMA UNAV
在 unav.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections
M Galarraga, J Campión, A Muñoz-Barrutia, N Boqué, H Moreno, ...
Journal of lipid research 53 (12), 2791-2796, 2012
4022012
A combined PD-1/C5a blockade synergistically protects against lung cancer growth and metastasis
D Ajona, S Ortiz-Espinosa, H Moreno, T Lozano, MJ Pajares, J Agorreta, ...
Cancer discovery 7 (7), 694-703, 2017
1962017
Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects
D Ajona, C Zandueta, L Corrales, H Moreno, MJ Pajares, ...
American journal of respiratory and critical care medicine 197 (9), 1164-1176, 2018
702018
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
I Garmendia, MJ Pajares, F Hermida-Prado, D Ajona, C Bértolo, C Sainz, ...
American journal of respiratory and critical care medicine 200 (7), 888-899, 2019
662019
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
S Ortiz-Espinosa, X Morales, Y Senent, D Alignani, B Tavira, I Macaya, ...
Cancer letters 529, 70-84, 2022
622022
X-box binding protein 1 regulates unfolded protein, acute-phase, and DNA damage responses during regeneration of mouse liver
J Argemí, TR Kress, HCY Chang, R Ferrero, C Bértolo, H Moreno, ...
Gastroenterology 152 (5), 1203-1216. e15, 2017
492017
Tumor ENPP1 (CD203a)/Haptoglobin axis exploits myeloid-derived suppressor cells to promote post-radiotherapy local recurrence in breast cancer
B Ruiz-Fernandez de Cordoba, H Moreno, K Valencia, N Perurena, ...
Cancer discovery 12 (5), 1356-1377, 2022
312022
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
N Perurena, C Zandueta, S Martínez-Canarias, H Moreno, S Vicent, ...
Journal of hematology & oncology 10, 1-12, 2017
282017
Id1 and PD-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-L1 expression and tumor infiltrating CD8+ T cells
I Baraibar, M Roman, M Rodríguez-Remírez, I López, A Vilalta, ...
Cancers 12 (11), 3169, 2020
132020
The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma
I Lasheras-Otero, I Feliu, A Maillo, H Moreno, M Redondo-Muñoz, P Aldaz, ...
Journal of Investigative Dermatology 143 (2), 305-316. e5, 2023
102023
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
R Entrialgo-Cadierno, C Cueto-Ureña, C Welch, I Feliu, I Macaya, L Vera, ...
Molecular cancer 22 (1), 86, 2023
82023
A combined PD-1/C5a blockade synergistically protects against lung cancer growth and metastasis. Cancer Discov. 2017; 7 (7): 694–703. doi: 10.1158/2159-8290
D Ajona, S Ortiz-Espinosa, H Moreno, T Lozano, MJ Pajares, J Agorreta, ...
CD-16-1184.[Abstract][CrossRef][Google Scholar], 0
8
LAMC2 regulates key transcriptional and targetable effectors to support pancreatic cancer growth
O Erice, S Narayanan, I Feliu, R Entrialgo-Cadierno, A Malinova, ...
Clinical Cancer Research 29 (6), 1137-1154, 2023
72023
Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma
C Rodríguez-Nogales, H Moreno, C Zandueta, D Desmaële, F Lecanda, ...
Cancers 12 (7), 1895, 2020
72020
P3. 07-007 Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis
D Ajona, C Zandueta, L Corrales, H Moreno, M Pajares, S Ortiz-Espinosa, ...
Journal of Thoracic Oncology 12 (11), S2300, 2017
12017
MA09. 01 Dual Blockade of PD-1 and C5a/C5aR Synergistically Protects against Non-Small Cell Lung Cancer Tumor Growth
D Ajona, S Ortiz, H Moreno, S Vicent, L Montuenga, F Lecanda, R Pio
Journal of Thoracic Oncology 12 (1), S391, 2017
12017
Combined treatment with the epigenetic drug CM272 and an anti-BCL-XL proapoptotic drug sensitizes solid tumors to immune checkpoint blockade
Y Senent, V Fresquet, V Jimenez, K Valencia, A Remirez, F Exposito, ...
Cancer Research 83 (7_Supplement), 5117-5117, 2023
2023
Anticancer peptides
SE MARTÍN, L Nevola, FL Cordero, HM MORENO
US Patent 11,440,939, 2022
2022
A first-in-class c-MYC inhibitor shows in vivo efficacy in lung cancer models and has appropriate drug-like characteristics
H Moreno, BR Fernández-de-Córdoba, C Zandueta, S Martínez-Canarias, ...
Cancer Research 81 (13_Supplement), 1264-1264, 2021
2021
LAMC2 as a therapeutic target in pancreatic ductal adenocarcinoma
O Erice, E Blanco, K Valencia, E Guruceaga, H Moreno, F Lecanda, ...
Cancer Research 80 (16_Supplement), 6041-6041, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20